PDF
Abstract
In order to investigate the effects of TGF-β1 on the expression of MMP-2, −9 and TIMP-1 in human retinal pigment epithelial (RPE) cells, the third-sixth passage cultured RPE cells were treated with TGF-β1 at different concentrations (0. 01, 0. 1, 1. 0, 10 ng/mL), the expression of MMP-2, −9 and TIMP-1 mRNA was detected by semi-quantitative RT-PCR assays. MMP-2, −9 and TIMP-1 mRNA were expressed in the cultured RPE cells. The values of MMP-2/β-actin in the cells treated with 0. 1, 1. 0, 10 ng/mL TGF-β1 were 1.04±0.04, 1.07±0.02 and 1.11±0.03, respectively, significantly higher than in the control group (0.96±0.03,P<0.05–0.01). The expression of MMP-2 mRNA could be up-regulated by TGF-β1, in a dose-dependent manner. The expression of MMP-9 mRNA in the cultured RPE cells was slightly up-regulated by various TGF-β1 concentrations treatment. The values of TIMP-1/β-actin in the cells treated with 0.01 and 0.1 ng/ mL TGF-β1 were 0.85±0.01 and 0.97±0.02 respectively, significantly lower than in the control group (1.07±0.04,P<0.01), indicating that the expression of TIMP-1 mRNA was down-regulated by TGF-β1 at low concentrations. But along with the increase of TGF-β1 concentrations (1.0 and 10 ng/mL), the expression of TIMP-1 mRNA was slightly up-regulated, not significantly different from that in the control group (P>0.05). It was concluded that TGF-β1 might play an important role in the up-regulation of the expression of MMP-2 in RPE cells and result in a directional shift in the balance between MMP and TIMP. This may be facilitated for RPE cells to migrate in the pathogenesis of vitreoretinopathy.
Keywords
matrix metalloproteinase
/
tissue inhibitor of matrix metalloproteinase
/
transforming growth factor β1
/
human retinal pigment epithelial cells
Cite this article
Download citation ▾
Zeng Aiping, Zeng Shuiqing, Cheng Yang, Xiao Qing.
Modulation of matrix metalloproteinase and TIMP-1 expression by TGF-β1 in cultured human RPE cells.
Current Medical Science, 2006, 26(32): 363-365 DOI:10.1007/BF02829577
| [1] |
BrewK, DinakarpandianD, NagaseH. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta, 2000, 1477: 267-283
|
| [2] |
PadgettL C, LuiG M, WerbZ, et al.. Matrix metallo-proteinase-2 and tissue inhibitor of metalloproteinase-1 in the retinal pigment epithelium and interphotoreceptor matrix: vectorial secretion and regulation. Exp Eye Res, 1997, 64: 927-938
|
| [3] |
HiscottP, SheridanC, MageeR M, et al.. Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog Retinal Eye Res, 1999, 18: 167-190
|
| [4] |
LiD Q, LokeshwarB L, SolomonA, et al.. Regulation of MMP-9 production by human corneal epithelial cells. Exp Eye Res, 2001, 73: 449-459
|
| [5] |
ZengA P, ZengS Q, GuoH P, et al.. Regulation of matrix metalloproteinase-2 production by TGF-β1 in human RPE cells. Acta Med Univ Sci Technol Huazhong (Chinese), 2005, 34: 594-596
|
| [6] |
WiedemannP. Growth factors in retinal disease: proliferative vitreoretinopathy, proliferative diabetic retinopathy and retinal degeneration. Surv Ophthalmology, 1992, 36: 373-384
|
| [7] |
HuntR C, FoxA, PakalnisV, et al.. Cytokines cause cultured retinal pigment epithelial cells to secrete metalloproteinases and to contract collagen gels. Invest Ophthalmo Vis Sci, 1993, 34: 3179-3186
|